Korro Bio, Inc. - Schedule 13G Filing

Point72 Asset Management, L.P. and its affiliated entities, along with Steven A. Cohen, have filed a Schedule 13G statement regarding their beneficial ownership of Korro Bio, Inc. common stock. As of March 10, 2026, Point72 Asset Management, L.P. holds 540,054 shares, representing 3.7% of the outstanding shares. Steven A. Cohen, through various controlled entities, beneficially owns an aggregate of 816,885 shares, constituting 5.7% of the outstanding common stock. The filing confirms that these securities were not acquired or held for the purpose of changing or influencing the control of the issuer.